South Africa scraps AstraZeneca, pivots to Johnson & Johnson vaccine
South Africa has offered its stock of Oxford-AstraZeneca Covid-19 vaccines to the African Union, a senior health official said, as the country pivots to using shots developed by Johnson & Johnson instead. The country paused its rollout of the Oxford-AstraZeneca vaccine after preliminary trial data showed it offered minimal protection against mild to moderate illness
Continue Reading